Clorox Company (The) (CLX) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.55
- Estimate
- $1.07
- Surprise
- +45.2%
- Revenue (period 2026-09-30)
- $1.91B
- Score at report (before → after)
- 4.7 → 4.7/10
Revenue source: xbrl.
How the report landed
Clorox Company (The) (CLX) beat the $1.07 estimate with adjusted EPS of $1.55 — a large 45.2% upside surprise. TrendMatrix's engine moved from Buy (Wait) (4.7/10) to Sell at 4.7/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CLX Sell at 4.8/10.
3 of the last 4 quarters beat the estimate; this quarter's +45.2% surprise compares with a +12.3% four-quarter average.
What supports the rating
- Sector modifier (Consumer Defensive): +0.8
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Supplier: sole source or single-source suppliers
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $89.90
- Stop
- $85.00
The stock trades at 18.7× trailing but 14.7× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-03 — shown for context, not personalized investment advice.
CLX at TrendMatrix's latest read
Defensive staples are judged on margin resilience: pricing power against input costs matters more here than top-line drama.
- Industry
- Household & Personal Products
- Market cap
- $10.87B
- P/E (fwd)
- 14.7
- P/E (ttm)
- 18.7
- 52-week range
- $79.12–$128.90
- Off 52-week high
- 30.3%
- RSI (14)
- 66
- Volume vs avg
- 1.44×
- Score today
- 4.8/10